These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8844339

  • 21. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A, Mistry D, Loke D, Dunn G, Hough V, Oliver K, Stafford N, Greenman J.
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [Abstract] [Full Text] [Related]

  • 22. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
    Bajaj JS, Singh A, Aggarwal SK, Chattopadhya D, Baveja UK.
    J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
    [Abstract] [Full Text] [Related]

  • 23. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J, Scott DR, Glass AG, Rush BB, Lorincz AT, Corrigan A, Burk RD, Helgesen K, Houghten RA, Sherman ME, Kurman RJ, Berzofsky JA, Kramer TR.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [Abstract] [Full Text] [Related]

  • 24. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production.
    O'Hara RJ, Greenman J, MacDonald AW, Gaskell KM, Topping KP, Duthie GS, Kerin MJ, Lee PW, Monson JR.
    Clin Cancer Res; 1998 Aug; 4(8):1943-8. PubMed ID: 9717823
    [Abstract] [Full Text] [Related]

  • 25. Predictive value of interleukin-6 and neopterin in patients with multiple myeloma.
    Reibnegger G, Krainer M, Herold M, Ludwig H, Wachter H, Huber H.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6250-3. PubMed ID: 1933885
    [Abstract] [Full Text] [Related]

  • 26. Melatonin as a new possible anti-inflammatory agent.
    Lissoni P, Rovelli F, Meregalli S, Fumagalli L, Musco F, Brivio F, Brivio O, Esposti G.
    J Biol Regul Homeost Agents; 1997 Dec 01; 11(4):157-9. PubMed ID: 9582617
    [Abstract] [Full Text] [Related]

  • 27. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep 01; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 28. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
    Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T.
    Arthritis Rheum; 2000 Mar 01; 43(3):617-27. PubMed ID: 10728756
    [Abstract] [Full Text] [Related]

  • 29. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ, Adachi I.
    Anticancer Res; 1999 Mar 01; 19(2B):1427-32. PubMed ID: 10365118
    [Abstract] [Full Text] [Related]

  • 30. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.
    Pediatrics; 2006 May 01; 117(5):e878-86. PubMed ID: 16618789
    [Abstract] [Full Text] [Related]

  • 31. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
    Kozłowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ.
    Rocz Akad Med Bialymst; 2003 May 01; 48():82-4. PubMed ID: 14737948
    [Abstract] [Full Text] [Related]

  • 32. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM.
    J Rheumatol; 2007 Jan 01; 34(1):89-96. PubMed ID: 17117487
    [Abstract] [Full Text] [Related]

  • 33. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease.
    Reibnegger G, Fuchs D, Fuith LC, Hausen A, Werner ER, Werner-Felmayer G, Wachter H.
    Cancer Detect Prev; 1991 Jan 01; 15(6):483-90. PubMed ID: 1782638
    [Abstract] [Full Text] [Related]

  • 34. [Postoperative Th1 and Th2 type cytokine changes in patients with esophageal squamous cell carcinoma and their clinical significance].
    Wei YC, Hu FB, Shen Y, Xu LH, Lin LS.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov 01; 24(11):1271-3. PubMed ID: 15567776
    [Abstract] [Full Text] [Related]

  • 35. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease.
    Bodolay E, Aleksza M, Antal-Szalmás P, Végh J, Szodoray P, Soltész P, Szegedi A, Szekanecz Z.
    J Rheumatol; 2002 Oct 01; 29(10):2136-42. PubMed ID: 12375323
    [Abstract] [Full Text] [Related]

  • 36. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, Deitch EA.
    Crit Care Med; 2003 Jun 01; 31(6):1722-9. PubMed ID: 12794411
    [Abstract] [Full Text] [Related]

  • 37. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL, Samsonov MY, Tilz GP, Beketova TV, Semenkova EN, Baranov A, Wachter H, Fuchs D.
    J Rheumatol; 1997 Apr 01; 24(4):666-70. PubMed ID: 9101499
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD.
    Eur J Surg Oncol; 2007 Mar 01; 33(2):208-12. PubMed ID: 17140760
    [Abstract] [Full Text] [Related]

  • 39. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y.
    Anticancer Res; 2006 Mar 01; 26(2A):1113-34. PubMed ID: 16619514
    [Abstract] [Full Text] [Related]

  • 40. The role of helper and regulatory T cells in the pathogenesis of vitiligo.
    Basak PY, Adiloglu AK, Ceyhan AM, Tas T, Akkaya VB.
    J Am Acad Dermatol; 2009 Feb 01; 60(2):256-60. PubMed ID: 19022528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.